Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. (Q43289669)
Jump to navigation
Jump to search
scientific article published in September 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose. |
scientific article published in September 2009 |
Statements
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose (English)
H J Milionis
A-D Agouridis
1 September 2009
1 reference